VIRTRATE-3- potassium citrate, trisodium citrate dihydrate, and citric acid monohydrate liquid
Virtus Pharmaceuticals
----------
Prescription Systemic Alkalinizing Dietary Supplement1
Virtrate-3 is an orally administered prescription systemic alkalinizing dietary supplement1 and should be administered under the supervision of a licensed medical practitioner.
Potassium citrate and sodium citrate are absorbed and metabolized to potassium bicarbonate and sodium bicarbonate, thus acting as systemic alkalinizing agents.
Supplement Facts | |||
---|---|---|---|
Serving Size: 1 Teaspoon (5 mL) | |||
Amount Per Serving | % Daily Value for Children Under 4 Years of Age | % Daily Value for Adults and Children 4 or More Years of Age | |
Potassium Citrate Monohydrate | 550 mg * | † | † |
Sodium Citrate Dihydrate | 500 mg * | † | † |
Citric Acid Monohydrate | 334 mg * | † | † |
Other Ingredients: Propylene Glycol, Sorbitol, Polyethylene Glycol 400, Sodium Benzoate, Sodium Saccharin, FD&C Yellow #6, Natural Raspberry Flavor and Purified Water.
Contains FD&C Yellow #6
Virtrate-3 is highly concentrated, and when consumed after meals and before bedtime, allows one to maintain an alkaline urine pH around the clock. When consumed as recommended, this product alkalinizes the urine without producing a systemic alkalosis. It is highly palatable and pleasant tasting. Potassium citrate and sodium citrate do not neutralize the gastric juice or disturb digestion.
Virtrate-3 should be taken diluted in water, followed by additional water, if desired. Palatability is enhanced if chilled before taking.
3 to 6 teaspoonfuls (15 to 30 mL), diluted in water, four times a day, after meals and at bedtime, or as directed by a physician.
1 to 3 teaspoonfuls (5 to 15 mL), diluted in water, four times a day, after meals and at bedtime, or as directed by a physician.
2 to 3 teaspoonfuls (10 to 15 mL), diluted with water, taken four times a day, will usually maintain a urinary pH of 6.5-7.4. 3 to 4 teaspoonfuls (15 to 20 mL), diluted with water, taken four times a day, will usually maintain a urinary pH of 7.0-7.6 throughout most of the 24 hours without unpleasant side effects. To check urine pH, HYDRION Paper (pH 6.0-8.0) or NITRAZINE Paper (pH 4.5-7.5) are available and easy to use.
Virtrate-3 is contraindicated in people with severe renal impairment with oliguria or azotemia, untreated Addison's disease, or severe myocardial damage. In certain situations, when people are on a sodium-restricted diet, the use of potassium citrate may be preferable; or, when people are on a potassium-restricted diet, the use of sodium citrate may be preferable.
Virtrate-3 should be used with caution by persons with low urinary output or reduced glomerular filtration rates unless they are under the supervision of a physician. Aluminum-based antacids should be avoided in these patients. Virtrate-3 should be diluted adequately with water and, preferably, taken after meals, to minimize the possibility of gastrointestinal injury associated with oral ingestion of potassium salt preparations and to avoid saline laxative effect. Persons with cardiac failure, hypertension, peripheral and pulmonary edema, and toxemia of pregnancy should use sodium salts cautiously.
Concurrent administration of potassium-containing supplements, potassium-sparing diuretics, angiotensin- converting enzyme (ACE) inhibitors, or cardiac glycosides may lead to toxicity. Persons with renal disease should have periodic determinations of serum electrolytes, particularly serum bicarbonate, in order to avoid these complications.
When consumes as recommended by people with normal renal function and urinary output, Virtrate-3 generally is well tolerated and has no unpleasant side effects. However certain patients with abnormal renal mechanisms should be careful to avoid development of hyperkalemia or alkalosis, especially in the presence of hypocalcemia. Potassium intoxication causes listlessness, weakness, mental confusion, and tingling of extremities.
Overdosage with sodium salts may cause diarrhea, nausea and vomiting, hypernoia, and convulsions. Overdosage with potassium salts may cause hyperkalemia and alkalosis, especially in the presence of renal disease.
Virtrate-3 is supplied as orange colored, raspberry flavored liquid dispensed in 16 fl. oz. (472 mL) bottles.
VIRTUS
PHARMACEUTICALS
76439-366-16
VIRTRATE-3
Potassium Citrate-Sodium
Citrate-Citric Acid
Prescription Systemic Alkalinizing
Dietary Supplement*
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.
Rx
16 fl. oz. (473mL)
Sugar-Free
Made in the USA
VIRTRATE-3
potassium citrate, trisodium citrate dihydrate, and citric acid monohydrate liquid |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Supplement Facts | ||
Serving Size : | Serving per Container : | |
Amount Per Serving | % Daily Value | |
---|---|---|
color | ||
flavor |
Labeler - Virtus Pharmaceuticals (969483143) |